Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946088 · ClinicalTrials.gov registry record · Phase 2
Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial
A Phase 2 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00946088: Clinical Trial Phase 2 study, sponsored by Stanford University.
NCT00946088 is a Phase 2 study that was terminated before completion, run by Stanford University. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946088, a Phase 2 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have sufficient evidence to use any medication to help prevent these women from delivering early. Recently, preliminary studies have shown that progesterone may help prevent some women at high risk for preterm delivery from delivering early. Our study will investigate whether progesterone can help this specific group of women, women with arrested preterm labor, deliver healthy infants at term.
Primary Outcome
Reduction in delivery rate prior to 37 weeks gestation (preterm birth).
Interventions
- DRUG Progesterone
- DRUG Polyethylene glycol&hydrogenated vegetable oil.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Why NCT00946088 stopped before completion
NCT00946088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Progesterone is the first listed.
NCT00946088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00946088 about?
NCT00946088 is a clinical study titled "Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial". Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have suffici...
What is the current status of trial NCT00946088?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2009-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT00946088?
The interventions under investigation include: Progesterone (DRUG), Polyethylene glycol&hydrogenated vegetable oil. (DRUG).
Who is sponsoring clinical trial NCT00946088?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00946088's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia